Association of anandamide and 2-arachidonoylglycerol concentrations with clinical features and body mass index in eating disorders and obesity
Abstract Background Anandamide (AEA) and 2-arachidonoylglycerol (2-AG) play a pivotal role in stimulating motivational behavior toward food and energy metabolism. Aberrant functioning of the endocannabinoid system has been observed in extreme weight conditions (EWCs), suggesting it may influence p...
Main Authors: | Isabel Baenas, Romina Miranda-Olivos, Roser Granero, Neus Solé-Morata, Isabel Sánchez, Antoni Pastor, Amparo del Pino-Gutiérrez, Ester Codina, Francisco J. Tinahones, José A. Fernández-Formoso, Núria Vilarrasa, Fernando Guerrero-Pérez, Rafael Lopez-Urdiales, Núria Virgili, Carles Soriano-Mas, Susana Jiménez-Murcia, Rafael de la Torre, Fernando Fernández-Aranda |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-01-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933823024112/type/journal_article |
Similar Items
-
Anandamide and 2-arachidonoylglycerol baseline plasma concentrations and their clinical correlate in gambling disorder
by: Isabel Baenas, et al.
Published: (2023-01-01) -
Peripheral endocannabinoids in eating disorders and obesity and its relationship with clinical and anthropometric variables
by: I. Baenas-Soto, et al.
Published: (2021-04-01) -
Anandamide Metabolites Protect against Seizures through the TRP Channel Water Witch in Drosophila melanogaster
by: Jack A. Jacobs, et al.
Published: (2020-06-01) -
Circulating endocannabinoid levels in pregnant women with gestational diabetes mellitus: a case–control study
by: Hadi Bazyar, et al.
Published: (2022-11-01) -
Inactivation of Anandamide Signaling: A Continuing Debate
by: Wael E. Houssen, et al.
Published: (2010-10-01)